Oat Breeders Develop Variety Higher in Beta Glucans
Plant breeders at the University of Wisconsin-Madison have developed an oat variety that features more beta glucans than common oats.
Plant breeders at the University of Wisconsin-Madison have developed BetaGene, a high-yield oat variety that features more beta glucans than the oats commonly available in today’s market.
Beta glucans have become a focal point for research, among other conditions, on heart health. Consumption of these compounds has been linked to cholesterol reductions, and FDA, EFSA, and Health Canada all have cardiovascular health claims for either oat fiber or oat beta glucans.
BetaGene is an estimated 2% higher in beta glucans than common varieties. While the increase sounds small, the University explains that it translates to a 20% boost in beta glucans in products ready to market.
The food industry has already taken interest in BetaGene, with at least one large milling company reported to have visited the area to learn more about the oat.
BetaGene is the result of a cross-breed developed in 1998.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
